Your browser doesn't support javascript.
loading
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
Coughlan, J J; Aytekin, Alp; Lahu, Shqipdona; Scalamogna, Maria; Wiebe, Jens; Pinieck, Susanne; Kufner, Sebastian; Xhepa, Erion; Joner, Michael; Kuna, Constantin; Voll, Felix; Laugwitz, Karl Ludwig; Schunkert, Heribert; Kastrati, Adnan; Cassese, Salvatore.
Afiliação
  • Coughlan JJ; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Aytekin A; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Lahu S; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Scalamogna M; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Wiebe J; Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
  • Pinieck S; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Kufner S; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Xhepa E; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Joner M; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Kuna C; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Voll F; DZHK (German Center for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.
  • Laugwitz KL; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Schunkert H; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Kastrati A; DZHK (German Center for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.
  • Cassese S; Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
EuroIntervention ; 18(16): e1328-e1338, 2023 Apr 03.
Article em En | MEDLINE | ID: mdl-36785947
ABSTRACT

BACKGROUND:

The treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is challenging as it has a high risk of recurrence.

AIMS:

The aim of this analysis was to develop and validate a model to predict the risk of repeat percutaneous coronary intervention (PCI) for recurrent DES-ISR.

METHODS:

A retrospective, observational analysis was performed including consecutive patients treated with PCI for DES-ISR at two centres in Germany. Included patients were randomly divided into training and validation cohorts. Two regression analyses identified factors associated with repeat PCI for recurrent DES-ISR up to 1 year. The discriminative ability of the resultant model was then compared to a benchmark ISR classification model using bootstrap resampling. A classification and regression tree analysis and a numerical scoring system (the ISAR score) were used to predict the risk of repeat PCI for recurrent DES-ISR based on the identified predictors.

RESULTS:

We included 1,986 patients in the current analysis, divided randomly into training (1,471 patients, 1,778 lesions) and validation (515 patients, 614 lesions) cohorts. Four factor variables (a non-focal ISR pattern, a time interval to ISR of <6 months, ISR of the left circumflex artery and ISR in a calcified vessel) were associated with repeat PCI for recurrent DES-ISR at 1-year follow-up. On bootstrap resampling analysis, the C-statistic for the model including these four variables was 0.60 (95% confidence interval [CI] 0.57-0.63), whereas the C-statistic for the benchmark ISR classification model was 0.54 (95% CI 0.52-0.57), a difference that was statistically significant (delta C-statistic 0.062; 95% CI 0.035-0.094; p<0.001). The cumulative incidence of repeat PCI for recurrent DES-ISR was over three times higher in DES-ISR lesions with an ISAR score of ≥3 in comparison to lesions with an ISAR score of 0.

CONCLUSIONS:

This study developed and validated a risk prediction model for repeat PCI for recurrent DES-ISR at 1-year follow-up. This model served to generate the ISAR score, a standardised tool that can be used to predict the 1-year risk of repeat PCI for recurrent DES-ISR.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reestenose Coronária / Stents Farmacológicos / Intervenção Coronária Percutânea Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reestenose Coronária / Stents Farmacológicos / Intervenção Coronária Percutânea Idioma: En Ano de publicação: 2023 Tipo de documento: Article